IL98078A0 - Pharmaceutical compositions comprising an anticytokyne - Google Patents

Pharmaceutical compositions comprising an anticytokyne

Info

Publication number
IL98078A0
IL98078A0 IL98078A IL9807891A IL98078A0 IL 98078 A0 IL98078 A0 IL 98078A0 IL 98078 A IL98078 A IL 98078A IL 9807891 A IL9807891 A IL 9807891A IL 98078 A0 IL98078 A0 IL 98078A0
Authority
IL
Israel
Prior art keywords
anticytokyne
pharmaceutical compositions
tbps
graft
versus
Prior art date
Application number
IL98078A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11062415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL98078(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL98078A priority Critical patent/IL98078A0/xx
Priority to CA002068027A priority patent/CA2068027C/en
Priority to AT92107685T priority patent/ATE184488T1/de
Priority to DE69233643T priority patent/DE69233643T2/de
Priority to AT98104718T priority patent/ATE334695T1/de
Priority to DK92107685T priority patent/DK0512528T3/da
Priority to EP92107685A priority patent/EP0512528B1/en
Priority to EP98104718A priority patent/EP0880970B1/en
Priority to ZA923310A priority patent/ZA923310B/xx
Priority to ES98104718T priority patent/ES2270479T3/es
Priority to DK98104718T priority patent/DK0880970T3/da
Priority to ES92107685T priority patent/ES2137935T3/es
Priority to US07/879,373 priority patent/US5512544A/en
Priority to DE69229975T priority patent/DE69229975T2/de
Priority to AU16094/92A priority patent/AU1609492A/en
Priority to PT98104718T priority patent/PT880970E/pt
Priority to JP15849492A priority patent/JP3320774B2/ja
Publication of IL98078A0 publication Critical patent/IL98078A0/xx
Priority to GR990402898T priority patent/GR3031805T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL98078A 1987-09-13 1991-05-07 Pharmaceutical compositions comprising an anticytokyne IL98078A0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IL98078A IL98078A0 (en) 1991-05-07 1991-05-07 Pharmaceutical compositions comprising an anticytokyne
CA002068027A CA2068027C (en) 1991-05-07 1992-05-05 Pharmaceutical compositions comprising an anticytokine
JP15849492A JP3320774B2 (ja) 1991-05-07 1992-05-07 薬剤組成物
ZA923310A ZA923310B (en) 1991-05-07 1992-05-07 Pharmaceutical compositions comprising an anticytokine
ES92107685T ES2137935T3 (es) 1991-05-07 1992-05-07 Preparaciones farmaceuticas que contienen una anticitoquina.
AT98104718T ATE334695T1 (de) 1991-05-07 1992-05-07 Verwendung von antizytokin-enthaltenden pharmazeutische zusammensetzungen zur therapie von multipler sklerose
DK92107685T DK0512528T3 (da) 1991-05-07 1992-05-07 Farmaceutisk præparat omfattende et cytokin
EP92107685A EP0512528B1 (en) 1991-05-07 1992-05-07 Pharmaceutical compositions comprising an anticytokine
EP98104718A EP0880970B1 (en) 1991-05-07 1992-05-07 Use of pharmaceutical compositions comprising an anticytokine for the therapy of multiple sclerosis
AT92107685T ATE184488T1 (de) 1991-05-07 1992-05-07 Pharmazeutische zusammensetzungen, die ein anticytokin enthalten
ES98104718T ES2270479T3 (es) 1991-05-07 1992-05-07 Utilizacion de composiciones farmaceuticas que contienen una anticitoquina para el tratamiento de esclerosis multiple.
DK98104718T DK0880970T3 (da) 1991-05-07 1992-05-07 Anvendelse af farmaceutiske præparater der omfatter et anticytokin, til behandling af dissemineret sklerose
DE69233643T DE69233643T2 (de) 1991-05-07 1992-05-07 Verwendung von Antizytokin-enthaltenden pharmazeutischen Zusammensetzungen zur Therapie von multipler Sklerose
US07/879,373 US5512544A (en) 1987-09-13 1992-05-07 Pharmaceutical compositions comprising an anticytokine
DE69229975T DE69229975T2 (de) 1991-05-07 1992-05-07 Pharmazeutische Zusammensetzungen, die ein Anticytokin enthalten
AU16094/92A AU1609492A (en) 1991-05-07 1992-05-07 Pharmaceutical compositions comprising an anticytokine
PT98104718T PT880970E (pt) 1991-05-07 1992-05-07 Composições farmacêuticas que compreendem uma anticitoquina para a terapia de esclerose múltipla.
GR990402898T GR3031805T3 (en) 1991-05-07 1999-11-10 Pharmaceutical compositions comprising an anticytokine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL98078A IL98078A0 (en) 1991-05-07 1991-05-07 Pharmaceutical compositions comprising an anticytokyne

Publications (1)

Publication Number Publication Date
IL98078A0 true IL98078A0 (en) 1992-06-21

Family

ID=11062415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98078A IL98078A0 (en) 1987-09-13 1991-05-07 Pharmaceutical compositions comprising an anticytokyne

Country Status (12)

Country Link
EP (2) EP0880970B1 (xx)
JP (1) JP3320774B2 (xx)
AT (2) ATE184488T1 (xx)
AU (1) AU1609492A (xx)
CA (1) CA2068027C (xx)
DE (2) DE69229975T2 (xx)
DK (2) DK0512528T3 (xx)
ES (2) ES2137935T3 (xx)
GR (1) GR3031805T3 (xx)
IL (1) IL98078A0 (xx)
PT (1) PT880970E (xx)
ZA (1) ZA923310B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
DE59010941D1 (de) 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
JPH09509646A (ja) * 1993-07-30 1997-09-30 ケネディー インスティチュート オブ リューマトロジー 多発性硬化症を治療する方法
HUT76666A (en) * 1994-07-22 1997-10-28 Hoffmann La Roche Pharmaceutical compositions comprising a chimaeric tnf binding protein
IL112834A (en) * 1995-03-01 2000-12-06 Yeda Res & Dev Pharmaceutical compositions for controlled release of soluble receptors
DE69525181T2 (de) * 1995-07-14 2002-08-14 Applied Research Systems Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
CA2273850A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
EP2002846B1 (en) 1996-12-06 2017-01-25 Amgen Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL127851A0 (en) * 1998-12-30 1999-10-28 Applied Research Systems Inhibition of TNF activity
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
US7674453B2 (en) * 2002-02-06 2010-03-09 Ares Trading Sa Tumor necrosis factor combined with interferon in demyelinating diseases
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
JP2006517191A (ja) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド 共刺激因子を用いた併用療法
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
EA201891433A3 (ru) 2010-01-15 2019-02-28 Кирин-Эмджен, Инк. Состав антитела и терапевтические режимы
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
KR102530900B1 (ko) 2014-03-31 2023-05-12 암젠 케이-에이, 인크. 손발톱 및 두피 건선의 치료 방법
US10465003B2 (en) 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
DE59010941D1 (de) * 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
DE69017753T3 (de) * 1989-05-18 2013-06-20 Yeda Research And Development Co., Ltd. Tumor-Nekrosefaktor-Bindungsprotein II, seine Reinigung und spezifische Antikörper
DE69022559T2 (de) * 1989-12-13 1996-05-02 Yeda Res & Dev Expression des rekombinanten Tumor-Nekrosisfaktor-Bindungsproteins I (TBP-I).
GB2246569A (en) * 1990-06-15 1992-02-05 Charing Cross Sunley Research Tumour necrosis factor - alpha binding protein
GB9022648D0 (en) * 1990-10-18 1990-11-28 Charing Cross Sunley Research Polypeptide and its use
ATE190629T1 (de) * 1991-01-18 2000-04-15 Amgen Inc Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
IL99120A0 (en) * 1991-08-07 1992-07-15 Yeda Res & Dev Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK0512528T3 (da) 1999-12-20
JP3320774B2 (ja) 2002-09-03
EP0880970A1 (en) 1998-12-02
CA2068027A1 (en) 1992-11-08
DK0880970T3 (da) 2006-11-20
ES2137935T3 (es) 2000-01-01
GR3031805T3 (en) 2000-02-29
DE69229975T2 (de) 2000-05-11
EP0512528B1 (en) 1999-09-15
ATE334695T1 (de) 2006-08-15
DE69233643D1 (de) 2006-09-14
EP0512528A2 (en) 1992-11-11
DE69233643T2 (de) 2007-07-26
CA2068027C (en) 2003-09-23
EP0880970B1 (en) 2006-08-02
PT880970E (pt) 2006-12-29
EP0512528A3 (en) 1993-07-21
ATE184488T1 (de) 1999-10-15
AU1609492A (en) 1992-11-12
JPH05170661A (ja) 1993-07-09
DE69229975D1 (de) 1999-10-21
ZA923310B (en) 1993-01-27
ES2270479T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
IL98078A0 (en) Pharmaceutical compositions comprising an anticytokyne
EP0670730A4 (en) FUSION PROTEINS COMPRISING A TUMOR NECROSIS FACTOR RECEPTOR.
AU7079396A (en) Anti-galalpha(1,3)gal antibody binding peptides
EP0787802A3 (xx)
HK1025994A1 (en) A tumor necrosis factor related ligand
GR3000944T3 (en) Pharmaceutical composition containing thymus extract fractions
PL319040A1 (en) Modified proteins
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
AU1346488A (en) Arginine-depleted human tumor necrosis factor
AU7117687A (en) Combination therapy using interleukin-2 and tumor necrosis factor
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
EP0821969A3 (en) Medicinal Composition comprising TCF-II
AU1996388A (en) Proteins and protein compositions and their use
ZA9010036B (en) Expression of the recombinant tumor necrosis factor binding protein i(tbp-i)
IE891174L (en) Tumor necrosis factor formulations
IE882290L (en) Treatment of infections with tumor necrosis factor